![]()
The United States National Institute of Health has given the okay to Ivermectin as an option for use in Covid-19. One week after Dr. Paul Marik and Dr. Pierre Kory, founding members of the Front Line Covid-19 Critical Care Alliance (FLCCC), along with Dr. Andrew Hill, researcher and consultant to the World Health Organization (WHO), presented their data before the NIH Treatment Guidelines Panel, the NIH upgraded their recommendation on Ivermectin, making it an option for use in Covid-19.
This new designation upgraded the status of Ivermectin from “against” to “neither for nor against”, which is the same recommendation given to monoclonal antibodies and convalescent plasma, both widely used in the United States.
The FLCCC statements says that by the NIH no longer recommending against Ivermectin use, doctors should feel more open in prescribing Ivermectin as another...
Continue reading...
Last edited by a moderator: